Home > Biological aging markers in blood and brain tissue indicate age acceleration in alcohol use disorder.

Zillich, Lea and Cetin, Metin and Hummel, Elisabeth M and Poisel, Eric and Fries, Gabriel R and Frank, Josef and Streit, Fabian and Foo, Jerome C and Sirignano, Lea and Friske, Marion M and Lenz, Bernd and Hoffmann, Sabine and Adorjan, Kristina and Kiefer, Falk and Bakalkin, Georgy and Hansson, Anita C and Lohoff, Falk W and Kärkkäinen, Olli and Kok, Eloise and Karhunen, Pekka J and Sutherland, Greg T and Walss-Bass, Consuelo and Spanagel, Rainer and Rietschel, Marcella and Moser, Dirk A and Witt, Stephanie H (2024) Biological aging markers in blood and brain tissue indicate age acceleration in alcohol use disorder. Alcohol: Clinical and Experimental Research, 48, (2), pp. 250-259. https://doi.org/10.1111/acer.15241.

External website: https://onlinelibrary.wiley.com/doi/10.1111/acer.1...

BACKGROUND: Alcohol use disorder (AUD) is associated with increased mortality and morbidity risk. A reason for this could be accelerated biological aging, which is strongly influenced by disease processes such as inflammation. As recent studies of AUD show changes in DNA methylation and gene expression in neuroinflammation-related pathways in the brain, biological aging represents a potentially important construct for understanding the adverse effects of substance use disorders. Epigenetic clocks have shown accelerated aging in blood samples from individuals with AUD. However, no systematic evaluation of biological age measures in AUD across different tissues and brain regions has been undertaken.

METHODS: As markers of biological aging (BioAge markers), we assessed Levine's and Horvath's epigenetic clocks, DNA methylation telomere length (DNAmTL), telomere length (TL), and mitochondrial DNA copy number (mtDNAcn) in postmortem brain samples from Brodmann Area 9 (BA9), caudate nucleus, and ventral striatum (N = 63-94), and in whole blood samples (N = 179) of individuals with and without AUD. To evaluate the association between AUD status and BioAge markers, we performed linear regression analyses while adjusting for covariates.

RESULTS: The majority of BioAge markers were significantly associated with chronological age in all samples. Levine's epigenetic clock and DNAmTL were indicative of accelerated biological aging in AUD in BA9 and whole blood samples, while Horvath's showed the opposite effect in BA9. No significant association of AUD with TL and mtDNAcn was detected. Measured TL and DNAmTL showed only small correlations in blood and none in brain.

CONCLUSIONS: The present study is the first to simultaneously investigate epigenetic clocks, telomere length, and mtDNAcn in postmortem brain and whole blood samples in individuals with AUD. We found evidence for accelerated biological aging in AUD in blood and brain, as measured by Levine's epigenetic clock, and DNAmTL. Additional studies of different tissues from the same individuals are needed to draw valid conclusions about the congruence of biological aging in blood and brain.


Item Type
Article
Publication Type
International, Open Access, Article
Drug Type
Alcohol
Intervention Type
Harm reduction, Screening / Assessment
Date
February 2024
Identification #
https://doi.org/10.1111/acer.15241
Page Range
pp. 250-259
Volume
48
Number
2
EndNote

Repository Staff Only: item control page